Eric S Lander
Director · Science and Technology Policy
Summary
Eric S Lander (Executive branch) has disclosed 175 securities trades under OGE Form 278-T (0 buys / 175 sells), an estimated ~$28.61M; most-traded CDAKQ, VSTM, INFIQ. Post-disclosure direction-match rate 78%. Latest filing 2021-09-08. Public OGE Form 278-T filings are generally due within 45 days, but late filings occur; use the filing date shown. Not investment advice.
Primary source: OGE Form 278-T filing · 2021-09-08
Disclosed trades175
Buy / Sell0 / 175
Total amount (est.)$28.61M
Median filing lag89d
Latest filing2021-09-08
⚠️ Executive-branch (OGE 278-T) disclosures are hand-signed scans that are hard to parse by machine; this shows only trades with a recognizable ticker (not full holdings), tickers may have OCR errors, and amounts are disclosed ranges.
Large tradesNet sellerFrequent discloser
Disclosures concentrate in Health Care, Financials, Technology. Disclosure samples are limited and not a real, complete position.
Most-traded stocks
CDAKQ
CODIAK BIOSCIENCES INC
37× · 0B/37S
VSTM
VERASTEM INC
3× · 0B/3S
INFIQ
INFINITY PHARMACEUTICALS INC
2× · 0B/2S
BNTX
BIONTECH SE-ADR
2× · 0B/2S
JNCE
JOUNCE THERAPEUTICS INC
2× · 0B/2S
SE
SEA LTD-ADR
2× · 0B/2S
PEP
PEPSICO INC
2× · 0B/2S
MSCI
MSCI INC
2× · 0B/2S
SPGI
S&P GLOBAL INC
2× · 0B/2S
HD
HOME DEPOT INC
2× · 0B/2S
DOV
DOVER CORP
2× · 0B/2S
BAC
BANK OF AMERICA CORP
2× · 0B/2S
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.